Bexil Corporation Announces Second Quarter 2020 Financial Results
Bexil Corporation (OTC PINK: BXLC) reported financial results for the second quarter ending June 30, 2020. The company recorded a net income of approximately $1.46 million or $1.74 per diluted share, a significant increase from the $0.45 million or $0.50 per diluted share reported in Q2 2019. However, for the first half of 2020, Bexil incurred a net loss of approximately $4.01 million or $4.88 per share, in contrast to a net income of $2.60 million reported for the same period in 2019. The company’s book value per share was $21.86.
- Net income of $1.46 million in Q2 2020, up from $0.45 million in Q2 2019.
- Strong diluted earnings per share at $1.74 for Q2 2020 compared to $0.50 in Q2 2019.
- Book value per share improved to $21.86.
- Net loss of $4.01 million for the first half of 2020, contrasting with net income of $2.60 million in H1 2019.
- Ongoing uncertainty related to the impact of COVID-19 on the company’s financial condition.
NEW YORK, NY / ACCESSWIRE / August 12, 2020 / Bexil Corporation (OTC PINK:BXLC) ("Bexil" or the "Company") today reported its financial results for the second quarter ended June 30, 2020.
For the three months ended June 30, 2020, Bexil recorded net income attributable to Bexil shareholders of approximately
For the six months ended June 30, 2020, Bexil recorded a net loss attributable to Bexil shareholders of approximately
The Company's book value per share attributable to Bexil shareholders at June 30, 2020 was
The Company's unaudited consolidated balance sheet, statements of comprehensive income (loss), and statements of cash flows as of and for the six months ended June 30, 2020 are appended to the copy of this press release on www.Bexil.com.
Effects of COVID-19 on the Company
To the extent COVID-19 has caused prices of publicly traded securities generally to decline in 2020, it has indirectly impacted the Company's financial condition and results of operations because the Company's assets are substantially invested in such securities and revenue from its operations are largely dependent on the value of gross assets under management invested in such securities. The full impact of COVID-19 on the Company's financial condition and results of operations is uncertain and cannot be predicted at the current time as it depends on several factors beyond the control of the Company including, but not limited to the uncertainty around (i) the severity and duration of the outbreak, (ii) the effectiveness of the U.S. public health response, (iii) the pandemic's impact on the U.S. and global economies, (iv) the timing, scope, and effectiveness of additional governmental responses to the pandemic, (v) the timing and speed of economic recovery, including the availability of a treatment or vaccination for COVID-19, and (vi) the impact on financial markets. Due to these and similar factors, on May 19, 2020 a Company affiliate (the "Borrower") entered into a Paycheck Protection Program Term Note ("PPP Note") on behalf of itself and certain of its affiliates, including the Company (collectively, the "Affiliates"), under the Paycheck Protection Program of the recently enacted Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"). Interest accrues on the PPP Note at the rate per annum of
About Bexil Corporation
Bexil is primarily engaged through a wholly owned subsidiary in investment management. To learn more about Bexil, including Rule 15c2-11 information, please visit www.Bexil.com.
Safe Harbor Note
This release may contain certain "forward looking statements" within the meaning of federal securities laws including, but not limited to the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Bexil, which may cause the Company's actual results to be materially different from those expressed or implied by such statements. The Company may also make additional forward looking statements from time to time. All such subsequent forward looking statements, whether written or oral, by the Company or on its behalf, are also expressly qualified by these cautionary statements. Investors should carefully consider the risks, uncertainties, and other factors, together with all of the other information included in the Company's Annual Report, at http://www.bexil.com/cautionary-language.html, and similar information. All forward looking statements made herein are only made as of the date of this release, and the Company undertakes no obligation to publicly update such forward looking statements to reflect subsequent events or circumstances.
The Company views book value per share, a non-GAAP financial measure, as an important indicator of financial performance. Presented in conjunction with other financial information, the combined presentation can enhance an investor's understanding of the Company's underlying financial condition and results from operations. The definition of book value as presented in this press release is shareholders' equity attributable to Bexil shareholders divided by currently issued and outstanding shares.
Contact:
Thomas O'Malley
Chief Financial Officer
1-212-785-0900
tomalley@bexil.com
www.Bexil.com
SOURCE: Bexil Corporation
View source version on accesswire.com:
https://www.accesswire.com/601421/Bexil-Corporation-Announces-Second-Quarter-2020-Financial-Results
FAQ
What were Bexil Corporation's earnings for Q2 2020?
What is the book value per share for BXLC as of June 30, 2020?
How did COVID-19 affect Bexil Corporation's financial results?
What was the diluted earnings per share for Bexil in Q2 2020?